[Cl:1][C:2]1[N:7]=[C:6]([CH3:8])[N:5]=[C:4]([CH:9]2[CH2:11][CH:10]2[C:12](OCC)=[O:13])[CH:3]=1.[H-].[H-].[H-].[H-].[Li+].[Al+3].O.[OH-].[Na+]>C1COCC1>[Cl:1][C:2]1[N:7]=[C:6]([CH3:8])[N:5]=[C:4]([C@@H:9]2[CH2:11][C@H:10]2[CH2:12][OH:13])[CH:3]=1ethyl 2-(6-chloro-2-methylpyrimidin-4-yl)cyclopropanecarboxylate (4-2, 6.8 g, 28.3 mmol, 1.0 eq) was dissolved in THF (141 ml) and cooled to −40° C. with dry ice acetone bath. LAH (32.5 ml, 32.5 mmol, 1.2 eq) (1.0 M solution in THF) was added dropwise over 10 minutes. The reaction appeared complete. To the reaction mixture was added water at 0° C. as to not raise the internal reaction temperature above −10° C., followed by 15% aqueous sodium hydroxide solution (2 mL). The cooling bath was removed and additional water (6 mL) was added. The reaction mixture was stirred for 1 hour. The salts were filtered off through celite and the solid was washed with THF (5×20 mL). The filtrate was dried over sodium sulfate, filtered and concentrated. The residue was purified by silica gel column chromatography (0-100% ethyl acetate in hexanes) to afford ((1R,2R)-2-(6-chloro-2-methylpyrimidin-4-yl)cyclopropyl)methanol (4-3).
Loading…